Rothschild Investment LLC Compugen LTD Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Compugen LTD stock. As of the latest transaction made, Rothschild Investment LLC holds 191,400 shares of CGEN stock, worth $250,734. This represents 0.02% of its overall portfolio holdings.
Number of Shares
191,400
Previous 203,900
6.13%
Holding current value
$250,734
Previous $314 Million
10.98%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding CGEN
# of Institutions
77Shares Held
13.4MCall Options Held
44.9KPut Options Held
8.1K-
Silverarc Capital Management, LLC1.62MShares$2.13 Million0.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.28MShares$1.67 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.09MShares$1.43 Million0.85% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.34 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$1.3 Million0.06% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $113M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...